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Background
Huntington’s disease (HD) is a rare, inherited neurodegenerative
disorder. Clinical symptoms of HD encompass motor and non-motor
domains. Motor, cognitive, psychological, and behavioral functions
may be progressively impaired before the diagnosis of HD is made,1,2
and result in limitations of daily activities.3 In later disease stages,
patients are dependent on caregivers. To date, there is still no causa-
tive treatment for HD. Most treatment approaches intend to alleviate
HD symptoms, but none of them has a long-term disease-modifying
effect.4,5 Accordingly, the aim of symptomatic treatments is to main-
tain quality of life and independency for as long as possible.
Multiple approaches were introduced to cope with the diversity of
HD symptoms, encompassing physical, cognitive, and drug therapy.
Physical therapy was integrated in the treatment process decades ago
in order to attenuate impairments in motor function,6,7 and focused on
task-specific exercises to imitate and improve activities of daily living.
Studies with physical therapy interventions showed an improvement in
specific tasks or at least an attenuation of the natural disease progress
for these tasks.8–16
Based on the close relationship between some physical therapy
exercises and resistance or endurance exercise, interest was aroused in
whether the last two training modalities might have an effect in HD
patients. However, several years ago, the potential benefits of exercise
interventions were clouded by suspected disadvantages. On the one
hand, it was known that a passive lifestyle might lead to an earlier age
at symptom onset in HD patients,17 and that exercise exerts a positive
effect in other neurodegenerative diseases, e.g. amyotrophic lateral
sclerosis and Parkinson disease.18,19 On the other hand, a case study
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postulated a relationship between excessive endurance training and
acute myopathy with rhabdomyolysis in a semi-professional marathon
runner with premanifest HD.20 In conjunction with skeletal muscle
mitochondrial impairments in HD patients,21–24 a negative effect of
excessive training on skeletal muscle energy metabolism was suspected.
Nonetheless, based on the promising results of the first studies and
an overwhelming proportion of studies showing a positive effect of
exercise in the HD mouse model (for a review see Mo et al.25), several
studies investigated the effects of structured exercise training in HD
patients within the last 5 years.
In this article, we review and summarize the findings of previous
studies assessing the effects of targeted exercise training interventions
in HD patients. This review refers only to studies applying structured
endurance and/or resistance training programs with quantitative
outcome data in human patients. Readers interested in the effects of
physical therapy and multidisciplinary rehabilitation interventions in
HD are referred to a recent review by Fritz et al.26
Methods
We searched the PubMed, Scopus, Web of Science, and Google
Scholar databases using variant names of the disease, i.e. ‘‘Huntington
disease’’ or ‘‘Huntington’s disease’’, in combination with exercise
intervention-related terms, i.e. ‘‘exercise’’, ‘‘training’’, ‘‘endurance’’,
‘‘resistance training’’, ‘‘resistance exercise’’, ‘‘strength training’’, and
‘‘strength exercise’’. In addition, the reference lists of included articles
were screened for further candidate publications. The search was
restricted to articles in the English language involving human HD
patients. In the current review, we included scientific literature on
structured exercise intervention programs incorporating targeted
endurance and/or resistance training. Exercise training is defined as
a structured, purposefully planned activity that can be progressed by
means of volume and/or intensity changes. Quantitative data on the
effects of training were necessary for inclusion in the review. We
conducted the search in October 2018 and all publications up to the
date of the search were screened.
The search identified 1,407 candidate publications (Fig. 1). After
removal of duplicates (n5341), 1,066 candidate publications remained.
Afterwards, we screened the abstracts of all articles to check if they
fell in to the scope of this review. Based on the available abstracts,
1,003 articles were excluded because of lack of relevance. The full texts
of the remaining 63 articles were screened for eligibility. Fifty-seven
full-text articles were excluded for the following reasons: acute or cross-
sectional study (n530), reviews (n59), task-specific training (n59),
discontinuous training protocol (n53), insufficient description of exe-
rcise protocol (n52), no quantitative data (n51), and case studies
(n53). Finally, six publications were included in the review, two of
which were from our own research group (Table 1).
Results
Study characteristics
The training group size in the included studies consisted of nine to
16 HD patients who completed the interventions. The average age of
the participants was in all studies between 53 and 55 years with
reported standard deviation (SD) between 7 and 13 years. In two
publications, only male HD patients were included in the analyses. In
three studies, the proportion of male and female HD patients was
similar, while in a further study, sex of the patients was not reported.
The duration of the training interventions ranged between 8 and
26 weeks (Table 1). Frequency of training could be divided into
two categories (Table 1). On the one hand, patients were supervised
during every training session and had three training sessions per week
(four studies).28,30–32 On the other hand, patients had only one super-
vised training session per week. In addition, patients were advised to
exercise at home twice a week (two studies).27,29 Training protocols
differed largely between the studies. Most of the training protocols
(four studies)27–30 included endurance and resistance exercises, while in
our two publications,31,32 the results of an exclusive endurance training
intervention were presented. In the last two publications, endurance
training consisted of periods of constant-load moderate-intensity and
high-intensity interval protocols, as well as the combination of these
modalities. In the two studies with supervised and unsupervised train-
ing sessions, the supervised sessions consisted of constant-load low-/
moderate-intensity endurance training for 10–30 minutes and whole-
body resistance training, mainly targeting major muscle groups.27,29
Home-based training consisted of walking at a low exercise intensity.
In a further study, patients exercised three times a week at home with
an exercise DVD, including a whole-body resistance training pro-
gram.28 In addition, they were advised to go for a gradual progressive
walk at light subjective exercise intensity. Over all the studies, training
intensity for the supervised constant-load endurance exercise sessions
was between 55% and 85% of (age-predicted) maximum heart rate for
the constant-load session. In the high-intensity training protocol, the
target heart rate was 90–95% of predetermined peak heart rate.
Training intensity for the resistance training interventions was 60–70%
of one-repetition maximum,27 not reported,28 or was defined by sets
and repetitions,29,30 with the remark that patients were encouraged to
exceed these numbers to ensure training progression (Table 1).
Adverse events
Information about adverse events in response to the training inter-
vention was reported in all included publications (Table 2). Five studies
reported no related adverse events in the intervention group.27–29,31,32
Quinn et al.30 reported two adverse events in the intervention group.
Namely, recurrence of back pain (n51) and Wolf–Parkinson–White
syndrome (n51) were observed, which resulted in withdrawal of the
patients. In the same study, two serious adverse events were reported
in the control group (i.e. attempted suicide possibly related to the study
and a suicide unlikely to be related to the study).
Effects on motor function
Four studies reported the Unified Huntington’s Disease Rating
Scale (UHDRS) motor score or a modified UHDRS motor score
before and after the training intervention (Table 2).27,28,30,31 Two
studies reported lower motor scores after the intervention (22.3 in
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8 weeks and 22 in 12 weeks), with significant group 6 time inter-
actions, compared with alterations in a HD control group.28,30 Two
studies reported statistically not altered values (+3.9 in 12 weeks and
+0.8 in 26 weeks).27,31 In all four studies, information on the natural
disease progression of motor scores was also included. In one of our
publications, natural disease progression of the UHDRS motor score
was assessed in the 26 weeks before onset of the training intervention
in the same HD patients.31 The UHDRS motor score increased
significantly in this first inactive period by an average of 7.4 points,
while the increase was almost completely attenuated (+0.8) during the
training intervention. In the further three studies, data of a HD con-
trol group were reported. In all these studies, motor scores remained
within ¡3 points during the observation period.27,28,30
Effects on mobility
During the training intervention, self-selected gait speed was stable
in one study27 and improved in another study.28 Performance dur-
ing the 3-minute (one study)30 and 6-minute (one study)27 walk tests
were not altered in response to the training interventions. Repeated
chair stand test performance was not altered in two studies,27,30 but the
Figure 1. Flow Chart of the Study Selection Process.
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30-second chair stand test performance was improved in another
study.28 One study reported an improved result in the physical
performance test after the intervention.28
Effects on balance/postural stability and falls
Balance assessments indicated an improved (Berg Balance Scale)28
or not altered (Romberg test)27 outcome. Two studies reported that no
falls occurred in the intervention group during the study period,27,28
while a slightly lower number of falls was reported in the intervention
group than in the control group in a third study.30
Effects on cognition
Three studies assessed cognitive variables before and after the train-
ing intervention (Table 2).27,30,31 In most of the assessed cognitive
variables, stable values or no significant alterations could be detected
during the training interventions. In these studies, the UHDRS cogni-
tive score and/or the Hopkins Verbal Learning Test-Revised (HVLT-R),
verbal and category fluency, Stroop/color word interference test, trail
making trials, and symbol digit modalities tests were conducted.
Effects on cardiovascular function
In one of our publications with exclusive endurance training, imp-
rovements in VO2peak, peak power, and time-to-exhaustion at 85% of
peak power were observed (Table 2).31 Another study reported an
increase in predicted VO2max following resistance and endurance
training.30 In two further studies, heart rate at a submaximal cycling
power was not altered during the training intervention.27,29 One of
these later studies also reported stable blood pressures at a submaximal
cycling power.29
Effects on body composition
In one study, body composition analysis was performed by dual-
energy X-ray absorptiometry (Table 2).31 In this study, there were
no alterations in total body mass and lean mass, while fat mass was
significantly reduced after a 6-month endurance training interven-
tion.31 In two further studies, total body mass was reported. In one
study, patients exhibited a significant increase in total body mass,29
and in the other study, body mass remained constant in the inter-
vention group.30
Effects on mitochondrial function
In one of our own publications, absolute values for citrate synthase,
complex III, complex V, and succinate cytochrome c reductase activi-
ties, measured spectrophotometrically, increased significantly during
the intervention period (Table 2).32 In contrast, relative complex I and
II activities decreased similarly in HD patients and healthy control
participants. Mitochondrial respiration measurements in a subgroup
of patients revealed significantly improved mass-specific fatty acid
oxidative capacity, respiratory capacity of complex I, oxidative phos-
phorylation capacity, electron transport system capacity, and respira-
tory capacity of complex IV in response to the training intervention,
while mitochondria-specific respiratory capacities remained constant.
Effects on quality of life measures
In three studies, quality of life was assessed by the Short Form (36)
Health Survey (SF-36) or by the three-level version of the EuroQol
five-dimensional questionnaire (EQ-5D-3L; Table 2).27,28,30 Quality
of life was stable during the training interventions in two studies.28,30
In one study, the mental component of the SF-36 was improved after
the training intervention, while the other components of the SF-36
remained stable.27 The control groups in these studies did not exhibit
significant worsening of quality of life measures.
Discussion
In our current review, we included six studies on the effects of
structured and targeted exercise training in HD patients. A multitude
of outcome variables were investigated in these studies, including
variables on safety, motor function, cognition, cardiovascular and
mitochondrial function, body composition, and quality of life. Most of
the studies revealed improved or stable values for the investigated
variables during the intervention period.
Safety of the intervention is a main priority when implementing
a new treatment approach in HD patients. All the reviewed articles
included information about adverse events during the training inter-
vention. Except from one study,30 no training-related adverse events
were reported. Since the reported concomitant conditions were aggra-
vated during the training interventions, both patients were withdrawn
from the study.30 Based on the data available, endurance and resis-
tance training seem to be safe in HD patients. Nonetheless, in HD, any
accelerated worsening of any measured variable might also represent
a safety issue. The comparisons between the alterations of measured
variables during the training interventions and worsening during natural
disease progression will be discussed within every subsequent topic.
Skeletal muscle atrophy is supposed to be a primary health risk
in HD patients.33 However, several cross-sectional studies in early-
and mid-stage HD patients could not detect significant differences in
fat-free mass or lean mass in comparison to age-matched healthy
controls.31,34–36 These studies highlighted that observed alterations in
muscle mass in HD patients rely on a multitude of factors, e.g. physical
activity and nutrition. In theory, the increased skeletal muscle turnover
in response to physical activity and training might represent a risk for
HD patients prone to muscle atrophy. In contrast, an increased skeletal
muscle mass in response to resistance training would represent a pro-
mising option to alleviate this condition. Four of the included studies
did incorporate resistance exercises in the training program.27–30
Unfortunately, none of these studies determined body composition.
Two studies reported total body mass before and after the training
intervention. Total body mass was not altered in one study30 and was
significantly increased (,3 kg) in the other study.29 However, infor-
mation about the composition of these body mass alterations is lacking.
In a further study on multidisciplinary rehabilitation in HD patients,
incorporating resistance training in the exercise intervention, a signif-
icant increase in whole-body fat-free mass was reported.37 Based on
the available results, exercise training seems not to accelerate skeletal
muscle atrophy in HD patients. On the contrary, resistance training
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might even have the potential to increase body mass in early- and
mid-stage HD patients. Further investigations of structured resistance
training in HD patients with exact body composition measurements
are desirable. In addition, we would like to point out that every
training intervention should be accompanied by nutrition counseling
to prevent a loss of skeletal muscle mass due to inadequate energy and
protein intake.
In addition to skeletal muscle atrophy, skeletal muscle mitochon-
drial impairments are another constraint of peripheral tissue in HD
patients.21–24,38 The results of one of our own publications indicated
that mitochondrial content was increased in response to endurance
training, while mitochondrial quality remained stable.32 This result
emphasized that mitochondrial biogenesis is physiologically possible in
early- and mid-stage HD patients. Besides the increased mitochondrial
content, we also observed a rise in the overall capillary-to-fiber ratio
during endurance training. The baseline values and the increase in
capillarization were similar to the one measured in healthy control
participants, indicating that capillarization and angiogenesis are well
maintained in early- and mid-stage HD patients compared with that in
healthy controls.
Our aforementioned results implicate that oxygen exchange between
blood and muscle fibers and oxygen utilization of skeletal muscle fibers
are improved after endurance training. This represents one explana-
tion for the reported improvement in (predicted) VO2peak in two
studies. Otherwise, no study has measured cardiac output before and
after the training intervention, whereby information on cardiac adap-
tations remain unknown. Two studies that measured heart rate at a
submaximal cycling power question the occurrence of ventricular
hypertrophy in their patients.27,29 In both studies, the heart rate at a
similar cycling power was not altered before and after the training
intervention. Provided that significant ventricular hypertrophy was
present, a reduction in heart rate at an identical cycling intensity would
be expected. However, in both studies, no further cardiovascular
variables were reported, whereby it remains incomprehensible whether
the specific training protocols resulted in any cardiovascular adapta-
tion. Epidemiological studies on the immediate causes of death in HD
indicated that cardiovascular diseases are the second leading cause
behind pneumonia.39–41 Since it is well known that physical activity
and cardiovascular fitness lead to a reduction in cardiovascular morta-
lity in the general public,42,43 a similar effect might be present in HD
patients. However, two recent reviews have summarized incidences
of cardiac (autonomic) dysfunctions in HD patients and highlight
a potential cardiac risk.44,45 Hence, further data on cardiovascular
adaptations following exercise training interventions in HD patients
are required to elucidate health-related cardiovascular benefits and to
examine the effects on potential cardiac dysfunctions.
In most included studies, exercise training had a positive effect on
motor function. A quantification of the positive effect on the UHDRS
motor score is difficult due to the variability in the progression of
UHDRS motor scores in the control groups. Data in three studies
provide an inconsistent outcome regarding the natural disease pro-
gression of the UHDRS motor score.27,28,30 In one of our publications,
the natural disease progression of the UHDRS motor score was
markedly attenuated during the intervention phase.31 The value
attained for the natural disease progression in our own study was
markedly higher than the reported longitudinal change in the UHDRS
motor score in larger cohort studies (3.2¡8.4 in 6 months46 or 4.7 per
year47). The explanation for this latter comparison might be based on
the high interindividual variation in UHDRS motor score progres-
sion.48,49 For example, due to the low sample sizes in all training
intervention studies, no allocation of HD patients according to motor
subtypes was feasible. Further assessed motor functional variables,
namely gait speed, walk tests, and chair stand tests, exhibited stable
values during the training interventions.27,30 Only in the study by
Khalil et al.28 were significant improvements in the Berg Balance
Scale, gait speed, 30-second chair sit to stand test, and physical
performance test reported in relation to the HD control group.
However, for all these variables the significant improvement depicted
mainly a catch-up effect to the better baseline values of the control
group. Based on current results of exercise training on motor function,
natural disease progression of HD patients might be attenuated by the
interventions. Whether this attenuation has a functional benefit on
activities of daily living remains unknown. To gain further insights into
the functional benefit of training on activities of daily living, prolonged
interventions are necessary.
Over all studies, most assessed cognitive variables were not signif-
icantly altered during the training interventions. In comparison to the
natural disease progression for cognitive variables,50–53 it remains
ambiguous whether the training interventions highlight a stabilization
of values or slowing of the natural disease progression. In several large-
scale investigations, significant decreases in some, but not all, cognitive
test variables were detected after 12 months of observation, while these
alterations were consolidated after 24 and/or 36 months.50–52 Since
the duration of training interventions in the included studies ranged
from 8 to 26 weeks, the length of the observation period, but also the
relatively small size of intervention cohorts, might have been insuffi-
cient to detect significant alterations in cognitive variables. This argument
is supported by the non-altered cognitive variables in our 6-month
natural disease observation period,31 and by the statistically not sig-
nificant alterations in the HD control groups in other studies.27,30
Significant improvements in some cognitive variables were previou-
sly reported in studies on multidisciplinary rehabilitation in HD
patients.37,54 In one of these studies, significant improvements were
positively correlated with the change in gray matter volume in the
dorsolateral prefrontal cortex.54 This latter result might even point
to preserved neuroplasticity in HD patients.
Self-reported quality of life seems not to be influenced by exercise
training in HD patients, nor was it changed during the observation
phases in control groups. However, the results might be explained
by the low sensitivity of the questionnaires. While it is well known
that quality of life is inversely associated with increasing stages of
the disease55–58 and increased symptoms are associated with lower
quality of life,59,60 less is known about the magnitude of longitudinal
changes in quality of life.61 Indeed, there is currently no health-related
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quality of live measure recommended to measure change of severity
over time.62
Limitations of previous studies and future perspectives
The included studies have several limitations that might compro-
mise the outcome of these studies and, thereby, affect the interpreta-
tion in this review. First, training intensity for endurance exercise
programs was sometimes very low. While training intensity in the
supervised training session was moderate to high, home-based endur-
ance training consisted mainly of walking exercise. Since supervised
sessions were only conducted once per week and home-based walking
twice per week, the overall intensity of these endurance training pro-
tocols might not have been sufficient to achieve a significant training
effect. Furthermore, patients in the mid- or late-stage of the disease
might not be able to achieve a sufficiently high training stimulus due to
motor and cognitive impairment. Therefore, exercise training might
be a valid strategy to modulate disease symptoms only during early- to
mid-stages of HD. Second, in most studies incorporating resistance
exercise, important information about resistance exercise determi-
nants63 is missing. These deficits complicate the interpretation of
resistance training effects. We recommend that all relevant exercise
determinants are reported for resistance and endurance training
programs in future studies. Furthermore, it remains to be elucidated
which training volume, intensity, and modality best modulates disease
symptoms. Third, only one study included exact measurements of
body composition. Based on the potential risk that a training inter-
vention might accelerate skeletal muscle atrophy, training intervention
studies should incorporate exact body composition measurements and
nutrition counseling. Fourth, individual progress adumbrates that
adaptation to the training stimulus underlies large interindividual
variability. Therefore, studies with larger cohorts might shed more
light on the individual alterations in variables. Previous training pro-
grams were adapted to restrictions of patients and targeted to facilitate
exercise participation (e.g. home-based exercise or supported exercise
at a clinic to assure comfortable training sessions for the patients), but
were not individualized to enhance training adaptation. Moreover, the
effect of disease severity and stage of disease on adaptation to training
remains scarce. Fifth, most studies documented the intake of medica-
tion. Since it is well known that several active pharmaceutical ingre-
dients interact with training adaptation processes, study outcomes
might have been altered by drug intake. However, current data are
insufficient to draw conclusions about these influences.
Conclusions
Based on the six included studies in this review, exercise training
seems to be a safe and feasible treatment approach in HD patients.
These studies on exercise training interventions in HD patients point
to a beneficial effect of training on cardiovascular and mitochondrial
function. Training effects on cognition, motor function, and body
composition are less congruent, but overall evidence seems to support
a possible positive effect. However, our conclusions are based on small-
scale studies and cannot be transferred to all HD patients. To shed
more light on the effects of exercise training on the aforementioned
variables, longer-term intervention studies with larger HD cohorts are
desirable. For reasons of safety, it is recommended that all exercise
training interventions are accompanied by frequent assessments to
detect any accelerated worsening of symptoms.
References
1. Paulsen JS, Langbehn DR, Stout JC, Aylward E, Ross CA, Nance M,
et al. Detection of Huntington’s disease decades before diagnosis: the Predict-
HD study. J Neurol Neurosurg Psychiatry 2008;79:874–880. doi: 10.1136/jnnp.
2007.128728
2. Paulsen JS, Miller AC, Hayes T, Shaw E. Cognitive and behavioral
changes in Huntington disease before diagnosis. In: Feigin AS, Anderson KE,
editors. Huntington disease. Amsterdam, The Netherlands: Elsevier Science
BV; 2017. p 69–91. (Handbook of Clinical Neurology; vol. 144). doi: 10.1016/
B978-0-12-801893-4.00006-7
3. Roos RA. Huntington’s disease: a clinical review. Orph J Rare Dis 2010;5:
40. doi: 10.1186/1750-1172-5-40
4. Dayalu P, Albin RL. Huntington disease. Pathogenesis and treatment.
Neurol Clin 2015;33:101–114. doi: 10.1016/j.ncl.2014.09.003
5. Dickey AS, La Spada AR. Therapy development in Huntington disease:
from current strategies to emerging opportunities. Am J Med Genet 2018;176:
842–861. doi: 10.1002/ajmg.a.38494
6. Lavers A. An account of a weekly activity group with Huntington’s chorea
patients on a ling stay ward. Occup Ther 1981;44:387–392. doi: 10.1177/030802
268104401209
7. Peacock IW. A physical therapy program for Huntington’s disease
patients. Clinic Manag Phys Ther 1987;7:22–23.
8. Bohlen S, Ekwall C, Hellstro¨m K, Vesterlin H, Bjo¨rnefur M, Wiklund L,
et al. Physical therapy in Huntington’s disease—toward objective assessments?
Eur J Neurol 2013;20:389–393. doi: 10.1111/j.1468-1331.2012.03760.x
9. Ciancarelli I, Tozzi Ciancarelli MG, Carolei A. Effectiveness of intensive
neurorehabilitation in patients with Huntington’s disease. Eur J Phys Rehabil Med
2013;49:189–195.
10. Ciancarelli I, De Amicis D, Di Massimo C, Sandrini G, Pistarini C,
Carolei A, et al. Influence of intensive multifunctional neurorehabilitation on
neuronal oxidative damage in patients with Huntington’s disease. Funct Neurol
2015;30:47–52.
11. Mirek E, Filip M, Banaszkiewicz K, Rudzin´ska M, Szymura J, Pasiuta S,
et al. The effects of physiotherapy with PNF concept on gait and balance of
patients with Huntington’s disease – pilot study. Neurol Neurochir Pol 2015;49:
354–357. doi: 10.1016/j.pjnns.2015.09.002
12. Mirek E, Filip M, Chwała W. The influence of motor ability rehabili-
tation on temporal-spatial parameters of gait in Huntington’s disease patients
on the basis of a three-dimensional motion analysis system: An experimental
trial. Neurol Neurochir Pol 2018;49:354–357.
13. Piira A, van Walsem MR, Mikalsen G, Nilsen KH, Knutsen S, Frich JC.
Effects of a one year intensive multidisciplinary rehabilitation program for
patients with Huntington’s disease: a prospective intervention study. PLoS Curr
2013;5. doi: 10.1371/currents.hd.9504af71e0d1f87830c25c394be47027
14. Piira A, van Walsem MR, Mikalsen G, Øie L, Frich JC, Knutsen S.
Effects of a two-year intensive multidisciplinary rehabilitation program for
Mueller SM, Petersen JA, Jung HH Exercise in Huntington’s Disease: Review
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org Columbia University Libraries8
patients with Huntington’s disease: a prospective intervention study. Version 2.
PLoS Curr 2015;6. doi: 10.1371/currents.hd.2c56ceef7f9f8e239a59ecf2d94cddac
15. Quinn L, Debono K, Dawes H, Rosser AE, Nemeth AH, Rickards H,
et al. Task-specific training in Huntington disease: a randomized controlled
feasibility trial. Phys Ther 2014;94:1555–1568. doi: 10.2522/ptj.20140123
16. Zinzi P, Salmaso D, De Grandis R, Graziani G, Maceroni S, Bentivoglio A,
et al. Effects of an intensive rehabilitation programme on patients with
Huntington’s disease: a pilot study. Clin Rehabil 2007;21:603–613. doi: 10.1177/
0269215507075495
17. Trembath MK, Horton ZA, Tippett L, Collins VR, Churchyard A,
Roxburgh R. A retrospective study of the impact of lifestyle on age at onset of
Huntington disease. Mov Disord 2010;25:1444–1450. doi: 10.1002/mds.23108
18. Lui AJ, Byl NN. A systematic review of the effect of moderate intensity
exercise on function and disease progression in amyotrophic lateral sclerosis.
J Neurol Phys Ther 2009;33:68–87. doi: 10.1097/NPT.0b013e31819912d0
19. Speelman AD, van de Warrenbrug BP, van Nimwegen M, Petzinger
GM, Munneke M, Bloem BR. How might physical activity benefit patients
with Parkinson disease? Nat Rev Neurol 2011;7:528–534. doi: 10.1038/nrneurol.
2011.107
20. Kosinski CM, Schlangen C, Gellerich FN, Gizatullina Z, Deschauer M,
Schiefer J, et al.Myopathy as a first symptom of Huntington’s disease in a
marathon runner. Mov Disord 2007;22:1637–1640. doi: 10.1002/mds.21550
21. Arenas J, Campos Y, Ribacoba R, Martı´n Pharm MA, Rubio JC,
Ablanedo P, et al. Complex I defect in muscle from patients with Huntington’s
disease. Ann Neurol 1998;43:397–400. doi: 10.1002/ana.410430321
22. Ciammola A, Sassone J, Alberti L, Meola G, Mancinelli E, Russo MA,
et al. Increased apoptosis, Huntingtin inclusions and altered differentiation in
muscle cell cultures from Huntington’s disease subjects. Cell Death Differ 2006;13:
2068–2078. doi: 10.1038/sj.cdd.4401967
23. Lodi R, Schapira AH, Manners D, Styles P, Wood NW, Taylor DJ, et al.
Abnormal in vivo skeletal muscle energy metabolism in Huntington’s disease
and dentatorubropallidoluysian atrophy. Ann Neurol 2000;48:72–76. doi: 10.1002/
1531-8249(200007)48:1,72::AID-ANA11.3.0.CO;2-I
24. Saft C, Zange J, Andrich J, Mu¨ller K, Lindenberg K, Landwehrmeyer B,
et al. Mitochondrial impairment in patients and asymptomatic mutation
carriers of Huntington’s disease. Mov Disord 2005;20:674–679. doi: 10.1002/
mds.20373
25. Mo C, Hannan AJ, Renoir T. Environmental factors as modulators of
neurodegeneration: insights from gene-environment interactions in Huntington’s
disease. Neurosci Biobehav Rev 2015;52:178–192. doi: 10.1016/j.neubiorev.2015.
03.003
26. Fritz NE, Rao AK, Kegelmayer D. Physical therapy and exercise
interventions in Huntington’s disease: a mixed methods systematic review.
J Huntington Dis 2017;6:217–235. doi: 10.3233/JHD-170260
27. Busse M, Quinn L, Debono K, Karen J, Johnathan C, Rebecca P, et al.
A randomized feasibility study of a 12-week community-based exercise pro-
gram for people with Huntington’s disease. J Neurol Phys Ther 2013;37:149–158.
doi: 10.1097/NPT.0000000000000016
28. Khalil H, Quinn L, van Deursen R, Dawes H, Playle R, Rosser A, et al.
What effect does a structured home-based exercise programme have on people
with Huntington’s disease? A randomized, controlled pilot study. Clin Rehabil
2013;27:646–658. doi: 10.1177/0269215512473762
29. Dawes H, Collett J, Debono K, Quinn L, Jones K, Kelson MJ, et al.
Exercise testing and training in people with Huntington’s disease. Clin Rehabil
2015;29:196–206. doi: 10.1177/0269215514540921
30. Quinn L, Hamana K, Kelson M, Dawes H, Collett J, Townson J, et al.
A randomized, controlled trial of a multi-modal exercise intervention in Huntington’s
disease. Parkinsonism Relat Disord 2016;31:46–52. doi: 10.1016/j.parkreldis.2016.06.023
31. Frese S, Petersen JA, Ligon-Auer M, Mueller SM, Mihaylova V,
Gehrig SM, et al. Exercise effects in Huntington disease. J Neurol 2017;264:
32–39. doi: 10.1007/s00415-016-8310-1
32. Mueller SM, Gehrig SM, Petersen JA, Frese S, Mihaylova V, Ligon-
Auer M, et al. Effects of endurance training on skeletal muscle mitochond-
rial function in Huntington disease patients. Orph J Rare Dis 2017;12:184.
doi: 10.1186/s13023-017-0740-z
33. Zielonka D, Piotrowska I, Marcinkowski JT, Mielcarek M. Skeletal muscle
pathology in Huntington’s disease. Front Physiol 2014;5:380. doi: 10.3389/fphys.
2014.00380
34. Cubo E, Rivadeneyra J, Gil-Polo C, Armesto D, Mateos A, Mariscal-
Pe´rez N. Body composition analysis as an indirect marker of skeletal muscle
mass in Huntington’s disease. J Neurol Sci 2015;358:335–338. doi: 10.1016/j.jns.
2015.09.351
35. Pratley RE, Salbe AD, Ravussin E, Caviness JN. Higher sedentary
energy expenditure in patients with Huntington’s disease. Ann Neurol 2000;47:
64–70. doi: 10.1002/1531-8249(200001)47:1,64::AID-ANA11.3.0.CO;2-S
36. Su¨ssmuth SD, Mu¨ller VM, Geitner C, Landwehrmeyer GB, Iff S,
Gemperli A, et al. Fat-free mass and its predictors in Huntington’s disease.
J Neurol 2015;262:1533–1540. doi: 10.1007/s00415-015-7753-0
37. Thompson JA, Cruickshank TM, Penailillo LE, Lee JW, Newton RU,
Barker RA, et al. The effects of multidisciplinary rehabilitation in patients with
early-to-middle-stage Huntington’s disease: a pilot study. Eur J Neurol 2013;20:
1325–1329. doi: 10.1111/ene.12053
38. Gehrig SM, Petersen JA, Frese S, Mueller SM, Mihaylova V, Ligon-
Auer M, et al. Skeletal muscle characteristics and mitochondrial function in
Huntington’s disease patients. Mov Disord 2017;32:1258–1259. doi: 10.1002/
mds.27031
39. Lanska DJ, Lavine L, Lanska MJ, Schoenberg BS. Huntington’s disease
mortality in the United States. Neurology 1988;38:769–772. doi: 10.1212/WNL.
38.5.769
40. Solberg OK, Filkukova P, Frich JC, Billaud Feragen KJ. Age at death
and causes of death in patients with Huntington disease in Norway in 1986-
2015. J Hunt Dis 2018;7:77–86. doi: 10.3233/JHD-170270
41. Sorensen SA, Fenger K. Causes of death in patients with Huntington’s
disease and in unaffected first degree relatives. J Med Genet 1992;29:911–914.
doi: 10.1136/jmg.29.12.911
42. Fogelholm M. Physical activity, fitness and fatness: relations to mortality,
morbidity and disease risk factors. A systematic review. Obes Rev 2010;11:
202–221. doi: 10.1111/j.1467-789X.2009.00653.x
43. Nocon M, Hiemann T, Mu¨ller-Riemenschneider F, Thalau F, Roll S,
Willich SN. Association of physical activity with all-cause and cardiovascular
mortality: a systematic review and meta-analysis. Eur J Cardiovasc Prev Rehabil
2008;15:239–246. doi: 10.1097/HJR.0b013e3282f55e09
44. Abildtrup M, Shattock M. Cardiac dysautonomia in Huntington’s
disease. J Hunt Dis 2013;2:251–261. doi: 10.3233/JHD-130054
Exercise in Huntington’s Disease: Review Mueller SM, Petersen JA, Jung HH
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org Columbia University Libraries9
45. Zielonka D, Piotrowska I, Mielcarek M. Cardiac dysfunction in
Huntington’s disease. Exp Clin Cardiol 2014;20:2547–2554.
46. Huntington Study Group. Unified Huntington’s disease rating scale:
reliability and consistency. Mov Disord 1996;11:136–142. doi: 10.1002/mds.
870110204
47. Meyer C, Landwehrmeyer B, Schwenke C, Doble A, Orth M, Ludolph
AC, et al. Rate of change in early Huntington’s disease: a clinicometric analysis.
Mov Disord 2012;27:118–124. doi: 10.1002/mds.23847
48. Hart EP, Marinus J, Burgunder JM, Bentivoglio AR, Craufurd D,
Reilmann R, et al. Better global and cognitive functioning in choreatic
versus hypokinetic-rigid Huntington’s disease. Mov Disord 2013;28:1142–1145.
doi: 10.1002/mds.25422
49. Jacobs M, Hart EP, van Zwet EW. Progression of motor subtypes in
Huntington’s disease: a 6-year follow-up study. J Neurol 2016;263:2080–2085.
doi: 10.1007/s00415-016-8233-x
50. Snowden J, Craufurd D, Griffiths H, Thompson J, Neary D.
Longitudinal evaluation of cognitive disorder in Huntington’s disease. J Int
Neuropsychol Soc 2001;7:33–44. doi: 10.1017/S1355617701711046
51. Stout JC, Jones R, Labuschagne I, O’Regan AM, Say MJ, Dumas EM,
et al. Evaluation of longitudinal 12 and 24 month cognitive outcomes in
premanifest and early Huntington’s disease. J Neurol Neurosurg Psychiatry 2012;83:
687–694. doi: 10.1136/jnnp-2011-301940
52. Tabrizi SJ, Reilmann R, Roos RA, Durr A, Leavitt B, Owen G, et al.
Potential endpoints for clinical trials in premanifest and early Huntington’s
disease in the TRACK-HD study: analysis of 24 month observational data.
Lancet Neurol 2012;11:42–53. doi: 10.1016/S1474-4422(11)70263-0
53. Tabrizi SJ, Scahill RI, Owen G, Durr A, Leavitt BR, Roos PR, et al.
Predictors of phenotypic progression and disease onset in premanifest and early-
stage Huntington’s disease in the TRACK-HD study: analysis of 36-month
observational data. Lancet Neurol 2013;12:637–649. doi: 10.1016/S1474-4422
(13)70088-7
54. Cruickshank TM, Thompson JA, Dominguez JF, Reyes AP, Bynevelt M,
Georgiou-Karistianis N, et al. The effect of multidisciplinary rehabilitation on
brain structure and cognition in Huntington’s disease: an exploratory study.
Brain Behav 2015;5:e00312. doi: 10.1002/brb3.312
55. Carlozzi NE, Ready RE, Frank S, Cella D, Hahn EA, Goodnight SM,
et al. Patient-reported outcomes in Huntington’s disease: quality of life in neuro-
logical disorders (Neuro-QoL) and Huntington’s disease health-related quality
of life (HDQLIFE) physical function measures. Mov Disord 2017;32:1096–1102.
doi: 10.1002/mds.27046
56. Carlozzi NE, Schilling SG, Lai JS, Paulsen JS, Hahn EA, Perlmutter JS,
et al. HDQLIFE: development and assessment of health-related quality of life in
Huntington disease (HD). Qual Life Res 2016;25:2441–2455. doi: 10.1007/
s11136-016-1386-3
57. Read J, Jones R, Owen G. Quality of life in Huntington’s disease:
a comparative study investigating the impact for those with pre-manifest and
early manifest disease, and their partners. J Huntingtons Dis 2013;2:159–175.
58. Van Walsem MR, Howe EI, Ruud GA, Frich JC, Andelic N. Health-
related quality of life and unmet healthcare needs in Huntington’s disease.
Health Qual Life Outcomes 2017;15:6. doi: 10.1186/s12955-016-0575-7
59. Ready RE, Mathews M, Leserman A, Paulsen JS. Patient and care-
giver quality of life in Huntington’s disease. Mov Disord. 2008;23:721–726.
doi: 10.1002/mds.21920
60. Thorley EM, Iyer RG, Wicks P, Curran C, Gandhi SK, Abler V, et al.
Understanding how chorea affects health-related quality of life in Huntington
disease: an online survey of patients and caregivers in the United States. Patient
2018;11:547–559. doi: 10.1007/s40271-018-0312-x
61. Boileau NR, Stout JC, Paulsen JS, Cella D, McCormack MK,
Nance MA, et al. Reliability and validity of the HD-PRO-TriadTM,
a health-related quality of life measure designed to assess the symptom triad of
Huntington’s disease. J Huntingtons Dis 2017;6:201–215. doi: 10.3233/JHD-
170238
62. Mestre TA, Carlozzi NE, Ho AK, Burgunder JM, Walker F, Davis AM,
et al. Quality of life in Huntington’s disease: critique and recommendations
for measures assessing patient health-related quality of life and caregiver quality
of life. Mov Disord 2018;33:742–749. doi: 10.1002/mds.27317
63. Toigo M, Boutellier U. New fundamental resistance exercise determi-
nants of molecular and cellular muscle adaptations. Eur J Appl Physiol 2006;97:
643–663. doi: 10.1007/s00421-006-0238-1
Mueller SM, Petersen JA, Jung HH Exercise in Huntington’s Disease: Review
Tremor and Other Hyperkinetic Movements
http://www.tremorjournal.org Columbia University Libraries10
